Search

Strategic report 2024

Media

https://www.gsk.com/media/11859/strategic-report-2024.pdf

First published: 27 February 2025

Annual Report 2024

Media

https://www.gsk.com/media/11850/annual-report-2024.pdf

First published: 27 February 2025

2024 Annual Report on Form 20-F

Media

https://www.gsk.com/media/11872/2024-annual-report-on-form-20-f.pdf

First published: 03 March 2025

20 F 2020

Media

https://www.gsk.com/media/7971/20-f-2020.pdf

First published: 01 June 2022

Togo becomes first country in Africa to validate the elimination of lymphatic filariasis as a public health problem

Media

LF, commonly known as elephantiasis, is a debilitating disease caused by a parasite transmitted to humans through the bites of mosquitoes.

https://www.gsk.com/en-gb/media/press-releases/togo-becomes-first-country-in-africa-to-validate-the-elimination-of-lymphatic-filariasis-as-a-public-health-problem/

First published: 18 April 2017

GSK ranks 1st in the 2021 Access to Medicine Index with leading R&D pipeline for priority diseases

Media

Ranking reflects GSK leadership through access to its medicines and vaccines for people around the world.

https://www.gsk.com/en-gb/media/press-releases/gsk-ranks-1st-in-the-2021-access-to-medicine-index-with-leading-rd-pipeline-for-priority-diseases/

First published: 26 January 2021

GSK joins new global partnership to help defeat ten neglected tropical diseases by 2020

Media

GSK announced it has joined other global pharma companies and organisations in a united effort to defeat neglected tropical diseases.

https://www.gsk.com/en-gb/media/press-releases/gsk-joins-new-global-partnership-to-help-defeat-ten-neglected-tropical-diseases-by-2020/

First published: 30 January 2012

GSK announces £1 billion R&D investment over ten years to get ahead of infectious diseases in lower-income countries

Media

GSK announced £1bn investment over ten years to accelerate R&D dedicated to infectious diseases

https://www.gsk.com/en-gb/media/press-releases/gsk-announces-1-billion-rd-investment-over-ten-years-to-get-ahead-of-infectious-diseases-in-lower-income-countries/

First published: 23 June 2022

Improving access to healthcare

Responsibility

Our ambition is to make our medicines and vaccines accessible to those who need them, no matter where they live

https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/improving-access-to-healthcare/

First published: 27 February 2025

GSK publishes 2010 Corporate Responsibility Report

Media

In its CRR, GSK reiterated its commitment to building its business on strong values and ethical standards.

https://www.gsk.com/en-gb/media/press-releases/gsk-publishes-2010-corporate-responsibility-report/

First published: 27 March 2011